Des Atouts Changement Date
Adma Biologics USD 732.48M 48.28M 2026-09
Agenus USD 172.69M 13.76M 2026-06
AstraZeneca USD 119.92B 4.09B 2026-09
BioCryst Pharmaceuticals USD 591.07M 33.22M 2026-09
Cassava Sciences USD 100.06M 3.84M 2026-09
Geron USD 527.11M 8.1M 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
MannKind USD 722.62M 9.69M 2026-09
Merck USD 132.77B 2.97B 2026-09
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Moderna USD 13.47B 2.51B 2026-09
Novartis USD 117.15B 1.38B 2026-09
Novavax USD 888M 67.57M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Sanofi EUR 130.29B 1.23B 2026-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
TG Therapeutics USD 1.59B 47.38M 2026-09